Services > Company Profile > Quarterly Results
Cipla Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
500087
ISIN Demat
INE059A01026
Book Value
93.45
NSE Symbol
CIPLA
Div & Yield %
0.89757
Market Cap (Rs Cr.)
25046.4655
P/E
22.28214
EPS
14
Face Value
2
  Quarters : 
ParticularsMar 2012
(Rs Cr.)
Dec 2011
(Rs Cr.)
Sep 2011
(Rs Cr.)
Gross Sales1814.051711.471758.09
Other Operating Income51.5248.0446.19
Other Income 38.9532.7724.31
Total Income1904.521792.281802.33
Total Expenditure 1466.791366.551340.41
PBIDT437.73425.73461.92
Interest 2.257.362.38
PBDT435.48418.37459.54
Depreciation70.4675.7465.62
Tax73.2872.7284.95
Deferred Tax0.000.000.00
Reported Profit After Tax291.74269.91308.97
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item291.74269.91308.97
    
EPS (Unit Curr.)3.633.363.85
EPS (Adj) (Unit Curr.)3.633.363.85
Calculated EPS (Unit Curr.)3.633.363.85
Calculated EPS (Adj) (Unit Curr.)3.633.363.85
Calculated EPS (Ann.) (Unit Curr.)14.5313.4515.39
Calculated EPS (Adj) (Ann.) (Unit Curr.)14.5313.4515.39
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity160.58160.58160.58
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
    
Public Shareholding (No Of.Shares)506720722.00506720722.00506208722.00
Public Shareholding (% in Equity)63.1163.1163.05
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares295485978.00295485978.00295485978.00
Non Encumbered - % in Total Promoters Holding100.00100.00100.00
Non Encumbered - % in Total Equity36.8036.8036.80
    
PBIDTM(%)24.1324.8826.67
PBDTM(%)24.0124.4526.53
PATM(%)16.0815.7717.84